Epidemiology

• xxx

---

Etiology

• 5-Fluorouracil (5-FU) (see 5-Fluorouracil, [[5-Fluorouracil]])
• Afatinib (Gilotrif) (se Afatinib, [[Afatinib]])
• Axitinib (Inlyta) (see Axitinib, [[Axitinib]])
• Capecitabine (Xeloda, Teva-Capecitabine) (see Capecitabine, [[Capecitabine]])
• Cytarabine (Arabinofuranosyl Cytidine, ARA-C, Cytosine Arabinoside, Cytosar-U) (see Cytarabine, [[Cytarabine]])
• Docetaxel (Taxotere) (see Docetaxel, [[Docetaxel]])
• Doxorubicin (Adriamycin) (see Doxorubicin, [[Doxorubicin]]): liposomal
• Pazopanib (Votrient) (see Pazopanib, [[Pazopanib]])
• Sorafenib (Nexavar) (see Sorafenib, [[Sorafenib]])
• Sunitinib (Sutent) (see Sunitinib, [[Sunitinib]])

---

Physiology

• xxx

---

Diagnosis

• xxx

---

Clinical Manifestations

Other Manifestations

• xxx

---

Treatment

• xxx

---

References

• xxx